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CORONARY SINUS OSTIAL 
OCCLUSION DURING 
RETROGRADE DELIVERY OF 
CARDIOPLEGIC SOLUTION 
SIGNIFICANTLY IMPROVES 
CARDIOPLEGIC 
DISTRIBUTION AND 
EFFICACY 
This study documents the gross flow characteristics and capillary distribution of 
cardioplegic solution delivered retrogradely with the coronary sinus open versus 
closed. Methods: Five explanted human hearts from transplant recipients were used 
as experimental models. Hearts served as their own controls and received two doses 
of warm blood cardioplegic solution, each containing colored microspheres. The first 
dose was delivered through a retroperfusion catheter with the coronary sinus open 
and the second dose was delivered with the sinus occluded. Capillary flow was 
measured at twelve ventricular sites and gross flow was measured by examining 
coronary sinus regurgitation, thebesian vein drainage, and aortic eifluent (nutrient 
flow). Results: Coronary sinus ostial occlusion allowed for a significant decrease in 
total cardioplegic flow (1.74 + 0.40 ml/gm versus 1.06 +- 0.32 ml/gm; p < 0.05) to 
occur while maintaining an identical intracoronary sinus pressure. Ostial occlusion 
also resulted in an increase in the ratio of nutrient flow/total cardioplegic flow from 
32.3% --- 15.1% to 61.3% -4- 7.9% (p < 0.05). A statistically significant improvement 
in capillary flow was found at the midventricular level in the posterior intraventric- 
ular septum and posterolateral right ventricular free wall. This improvement was 
also documented for the intraventricular septum and right ventricle at the level of 
the apex. Conclusion: Coronary sinus occlusion during retrograde cardioplegia 
significantly improves cardioplegic delivery to the right ventricle and posterior 
intraventricular septum. Furthermore, the technique affords a significant improve. 
ment in nutrient cardioplegic flow while reducing the overall volume of cardioplegic 
solution administered. (J THORAC CARDIOVASC SURG 1995;109:941-7) 
Ehud Rudis, MD, Richard N. Gates, MD, Hillel Laks, MD, Davis C. Drinkwater, MD, 
Abbas Ardehali, MD, Alon Aharon, MD, and Paul Chang, BS, Los Angeles, Calif. 
R etrograde techniques for delivery of cardioplegic solution have greatly advanced the field of myo- 
cardial protection. The retrograde approach has 
been shown to provide superior cardioplegic deliv- 
ery to myocardium distal to acute coronary occlu- 
sions when compared with the antegrade ap- 
proach. 1-s Retrograde techniques greatly simplify 
and expedite the conduct of many procedures, par- 
ticularly those in which the aortic root is opened or 
the heart is positioned such that the aortic valve is 
rendered incompetent. Multiple reports attest o the 
clinical efficacy of both cold and warm cardioplegic 
solutions delivered retrogradely. TM As a result, the 
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use of retrograde delivery techniques has become 
widespread. 
Despite this, relatively little information is avail- 
able regarding the optimal clinical approach to 
retrograde delivery and distribution of cardioplegic 
solution, particularly in the human heart. During 
our group's early clinical experience using retro- 
grade delivery of blood cardioplegic solutions, we 
noted the following clinical observations: 
1. In procedures in which the right atrium was 
opened and cardioplegic solution was being deliv- 
ered retrogradely by a nonocclusive catheter placed 
into the coronary sinus, a significant volume of 
cardioplegic solution was noted to regurgitate back 
out the coronary sinus ostium. 
2. In nearly all cases in which cardioplegic solu- 
tion was being delivered retrogradely by a nonocclu- 
sive catheter placed into the coronary sinus, the 
posterior intraventricular vein was less tensely filled 
than other veins on the left ventricular ffee wall. 
3. In procedures in which the right atrium was 
opened and cardioplegic solution was being deliv- 
ered retrogradely into the coronary sinus, if a purse- 
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Mid-ventr ic le 
Fig. 1. Samples taken from the ventricles for microvas- 
cular flow analysis. RV, Right ventricle; LV, left ventricle. 
(From Gates RN, Laks H, Drinkwater DC, et al. Gross 
and Microvascular Distribution of Retrograde Cardiople- 
gia in Explanted Human Hearts. Ann Thorac Surg 1993; 
56:410-7. Published with permission.) 
string suture was placed about the coronary sinus 
ostium several changes occurred. First, a signifi- 
cantly lower volume of cardioplegic solution per 
gram heart weight could be delivered to achieve an 
identical coronary sinus pressure. Second, the pos- 
terior intraventricular vein filled similarly to other 
left ventricular f ee wall veins. Third, the amount of 
cardioplegic solution vented out the coronary artery 
ostia per volume delivered was rar greater. 
These observations led us to the hypothesis that 
coronary sinus ostial occlusion during retrograde 
delivery of cardioplegic solution alters cardioplegic 
distribution. The experiments presented within this 
article were designed to test this hypothesis in our 
previously described model of the explanted human 
heart. 12 
Materials and methods 
Five explanted human hearts were used for this study. 
These hearts were obtained from heart transplant recipi- 
ents with both a preoperative and postoperative histologic 
diagnosis of idiopathic cardiomyopathy with interstitial 
fibrosis. These patients had no history of cardiac or 
thoracic operations and had normal coronary artery anat- 
omy with no angiographic or pathologic evidence of 
atherosclerotic coronary artery disease. Use of explanted 
hearts was in accordance with the hospital autopsy re- 
search guidelines and was approved by the Department of 
Pathology, University of California at Los Angeles School 
of Medicine. 
At the time of orthotopic heart transplantation, ex- 
planted hearts were arrested in situ with 4°C blood 
cardioplegic solution delivered antegradely at 80 mm Hg 
for 2 minutes. The composition of the arresting solution 
was as previously describedJ 2 Hearts were then excised in 
the standard bicaval cardiectomy fashion, leaving a slightly 
shorter inferior vena cava-atrial cuff. This ensured that 
the coronary sinus and the venous drainage system of both 
the left and right ventricles was intact. Hearts were then 
placed in an iced saline solution and immediately trans- 
ferred to the laboratory for investigation. 
Hearts were weighed and prepared for retrograde 
perfusion. The left and right coronary ostia were identi- 
fied and cannulated with intravenous tubing filled with 
heparin and saline solution. A 10 mm polytetrafiuoroeth- 
ylene (PTFE) tube graft* was sutured end to end to the 
coronary sinus ostium with 6-0 Prolene sutures (Ethicon, 
Inc., Somerville, N.J.). The free atrial resection line was 
occluded with vascular clamps. The heart was emptied of 
any fluid and suspended in air by a heavy suture placed 
through the aorta and pulmonary artery. A coronary sinus 
retroperfusion catheter (NPC-014 Research Medical Inc., 
Midvale, Utah) with a self-inflating (but nonocclusive) tip 
was introduced through the PTFE tube into the coronary 
sinus. 
Warm blood cardioplegic solution (37 ° C) was prepared 
as previously described. 12 Additionally, 2,500,000 colored 
microspheres (15 -+ 5/~m) were added to the cardioplegic 
solution. The microsphere-containing solution was contin- 
uously agitated and delivered as previously outlined a2 for 
2 minutes at a pressure of 30 to 40 mm Hg. Pressure was 
monitored at the tip of the catheter by a dedicated 
pressure-monitoring line designed into the retroperfusion 
catheter. Etttuents from the right and left coronary arter- 
ies, the thebesian system (collected in the dependent body 
of the ventricles), and regurgitating about the PTFE tube 
were then collected and measured. A 0-0 silk suture was 
tied around the PTFE tube taut on the retroperfusion 
catheter (to prevent regurgitation and to mimic coronary 
sinus ostial occlusion). A second dose of warm blood 
cardioplegic solution with different colored microspheres 
was then given in the same fashion as just described. Thus 
each heart acted as its own control. Approximately 20 to 
30 seconds was required between injections to reprepare 
the model. This short period of time was not thought to be 
significant enough to induce a change in distribution of 
the second infusion related to interval ischemia. 
Thin slices of the heart were taken at the midventricular 
and apex level. For the midventricular slice, a 2.5 gm 
myocardial specimen was taken from the anterior, lateral, 
and posterior free walls of the left and right ventricles. An 
anterior, middle, and posterior specimen was taken from 
the intraventricular septum. At the level of the apex, a 
specimen was taken from the lateral eft ventricle, midin- 
traventricular septum, and the lateral right ventricle (Fig. 
1). 
All tissue specimens were processed according to the 
*Gore-Tex graft, registered trademark of W. L. Gore & Associ- 
ates, Inc., Elkton, Md. 
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Table I. Effluent data 
Open Closecl p Value 
Total CPG volume (ml/gm) 1.74 _+ 0.40 1.06 +_ 0.32 <0.05 
CS regurgitation volume/total CPG volume (%) 46.1 +_ 9.2 0.9 __ 0.9 <0.05 
Thebesian vein volume/total CPG volume (%) 22.1 _+ 3.8 34.5 +_ 4.6 <0.05 
Nutrient flow volume/total CPG volume (%) 32.3 +_ 15.1 61.3 _+ 7.9 <0.05 
CPG, Cardioplegia; CS, coronary sinus; Nutrient, aortic root etfiuent. 
procedures outlined by EZ-Trac Inc. (Los Angeles, 
Calif.), and the manufacture's names for the various 
reagents will be used hereafter. 13Each specimen was 
weighed and processed with 15 ml of Tissue Digesting 
Reagent 1. This involved placing the specimen i  a boiling 
water bath for 1 hour, vortex mixing for i minute, diluting 
to 40 ml with Tissue Digesting Reagent 2, and centrifuging 
for 30 minutes. Supernatant was removed and resus- 
pended in 4 ml of Tissue Microsphere Counting Reagent. 
The specimen was then washed on three occasions with 2 
ml of Tissue Counting Reagent. The sample was again 
centrifuged and the supernatant removed. Aliquots of this 
final specimen were then placed in an improved Neubauer 
hemocytometer (Hausser Scientific, Horsham, Pa.). 
Twelve chambers were counted for each specimen. The 
total number of microspheres recovered in each specimen 
was calculated as follows: 
Total microspheres = number counted/number of 
chambers x (0.9 mm) 3 × (1000 mm)3/ml × ml suspension 
where number counted is the number of colored micro- 
spheres counted, number of chambers i the number of 
chambers counted, (0.9 mm) 3 is the ruled volume of the 
chamber, and ml suspension is the final dilution volume. 
The number of microspheres in etttuent samples was 
determined by means of a similar protocol. 13 
Flow of blood cardioplegic solution to a given region 
was calculated from the equation: 
Qu = Qt × Nu/Nt 
where Qt is the total cardioplegia flow rate delivered by 
the calibrated roller pump [ml. (min)-1], Nu is the num- 
ber of microspheres in the specimen of interest, and Nt is 
the total number of microspheres counted in the total 
heart (2,500,000 - number of microspheres recovered in 
the effluents). Gross etttuents and microvascular flow rates 
were compared by the paired two-tailed Student's t test. 
Results 
E~luent data. Table I shows data regarding flow 
rates. This compares the mean and standard evia- 
tions of the live hearts for the open versus closed 
coronary sinus. Aortic root effluent was defined as 
nutrient flow because this indicates that the car- 
dioplegic solution has traversed the microvascula- 
ture and exited either the left or right coronary 
artery. 
Table II. Microvascular data (coronary sinus open 
versus closed) 
Anterior Lateral/mid Posterior 
LV 0.34 +_ 0.32 0.20 --- 0.26 0.11 + 0.13 
vs. vs. vs. 
0.25 +__ 0.30* 0.10 _+ 0.07* 0.26 -+ 0.28* 
RV 0.20 +_ 0.21 0.05 - 0.03 0.04 - 0.03 
vs. vs. vs. 
0.21 + 0.19" 0.17 +_ 0.13t 0.18 -+ 0.13t 
IVS 0.12 _+ 0.31 0.11 +_ 0.08 0.02 -+ 0.01 
vs. vs. vs. 
0.26 _+ 0.20* 0.24 + 0.17" 0.19 - 0.10t 
RV IVS LV 
Apex 0.11 _+ 0.07 0.14 + 0.12 0.12 + 0.18 
VS. VS. VS. 
0.23 -- 0.12"~ 0.35 --+ 0.23t 0.30 --+ 0.29* 
LV, Left ventricle; RV, right ventricle; WS, intraventricular septum. All 
flows are expressed inmilliliters per gram myocardium. 
*p > 0.05. 
tP < 0.05. 
Microvascular data. In Table II, flow is ex- 
pressed in milliliters per gram myocardium. Values 
are presented as the mean and standard eviation of 
the five hearts for the open versus closed coronary 
sinus. 
Discussion 
Achieving complete distribution of cardioplegic so- 
lution to all areas of the myocardium is considered 
optimal when planning strategies for myocardial pro- 
tectionJ 4As the clinical use of the retrograde delivery 
technique for cardioplegic administration has in- 
creased, so too has interest in documenting the distri- 
bution of the solution. Multiple animal studies in pigs 
or dogs have uniformly suggested that capillary flow to 
the posterior intraventricular septum and posterolat- 
eral free wall of the right ventricle is minimal or 
nonexistent when compared with the excellent flow 
noted for the left ventricle. 2'15-18 
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In human beings, however, less information is 
present. Using an intracapillary marker and ex- 
planted human hearts, our group has previously 
demonstrated that the microvasculature of the right 
ventricle is indeed perfused by retrograde tech- 
niques. 12 Nonetheless, further studies with ex- 
planted human hearts and colored microspheres 
have suggested that, per gram myocardium, the left 
ventricle receives threefold to fourfold more capil- 
lary flow than the right ventricle. 19 Using intraoper- 
ative contrast echocardiography, Allen, 2° Aron- 
son, 2~ and their associates have confirmed human 
right ventricular perfusion by retrograde delivery of 
cardioplegic solution. In Allen's study, cardioplegic 
distribution was four times higher to the left ventri- 
cle than to the right ventricle. 
These differences between animals and human 
beings with regard to the degree of right ventricular 
capillary perfusion can probably be explained on an 
anatomic basis. In human beings, the posterior 
intraventricular vein, which parallels the posterior 
descending coronary artery, most frequently emp- 
ties into the coronary sinus a few centimeters be- 
yond the coronary sinus ostium. In piglets, this 
vessel enters just at the coronary sinus ostium, or 
more frequently as a separate vein near the coronary 
sinus ostium. Despite this, the posterior intraven- 
tricular vein of the piglets receives ome retrograde 
coronary sinus perfusion through the rich veno- 
venous and venothebesian connections present 
throughout he myocardium. We believe the ob- 
served differences between animals and human be- 
ings with regard to retrograde cardioplegic distribu- 
tion is a result of the anatomic differences in the 
posterior intraventricular vein and venovenous/ 
venothebesian systems. 
During our group's early experience using retro- 
grade delivery of blood cardioplegic solution for 
procedures in which the right atrium was opened, 
we noted that a significant amount of infused car- 
dioplegic solution simply regurgitated about the 
coronary sinus ostium. By placing a pursestring 
suture about the ostium, we eliminated this regur- 
gitation and noted several changes. First, a signifi- 
cantly lower volume of cardioplegic solution per 
gram heart weight could be delivered to achieve an 
identical coronary sinus pressure. Second, the pos- 
terior intraventricular vein appeared to be more 
tensely distended and filled more like left ventricu- 
lar free wall veins. Finally, the volume of cardiople- 
gic solution vented out the coronary artery ostia per 
volume delivered was far greater. 
Because of these observations, we sought o doc- 
ument the change in cardioplegic distribution 
achieved by coronary sinus ostial occlusion during 
retrograde delivery of cardioplegic solution. The 
results of this study indicate that coronary sinus 
ostial occlusion has several profound effects on 
retrograde cardioplegic flow and distribution. In- 
deed, with routine retrograde administration 
46.1% _+ 9.2% of the cardioplegic dose was found to 
regurgitate around the nonocclusive self-inflating 
distal cannula balloon and out the coronary sinus. 
By coronary sinus ostial occlusion, a statistically 
significant decrease in cardioplegic volume admin- 
istered (1.74 _+ 0.40 tal/gin versus 1.06 + 0.32 
tal/gin) could be achieved while maintaining identi- 
cal intracoronary sinus pressure. The percentage of 
the total cardioplegic dose delivered that exited the 
coronary artery ostia also significantly increased 
from 32.3% _+ 15.1% to 61.3% + 7.9%. We consider 
flow returned through the coronary artery ostia to 
represent nutrient flow because this cardioplegic 
solution has traversed the capillaries to exit through 
the coronary arteries. Thus coronary sinus occlusion 
during retrograde cardioplegic administration sig- 
nificantly improves its efficacy. The clinical benefits 
of this are relatively straightforward and primarily 
include a reduced potassium and crystalloid volume 
load. 
Coronary sinus ostial occlusion also had an effect 
on relative capillary flow through the myocardium. 
At the midventricular level, flow was decreased to 
the anterior and lateral eft ventride, although this 
was not a statistically significant difference. Flow was 
increased in all sections of the intraventricular sep- 
turn, and this difference reached statistical signifi- 
cance at the midventricular-posterior int aventricu- 
lar septum and at the apex-intraventricular septum. 
Of greatest interest was that capillary flow greatly 
increased to all regions of the right ventrMe. This 
increase was highly significant in the lateral and 
posterior egions of the right ventricle at the mid- 
ventricular level. These flow rates then approach an 
even to one-half level when compared with all other 
regions of the heart examined. We believe that these 
findings were the direct result of the equivalent 
pressure perfusion in the posterior intraventricular 
vein when compared with the distal coronary sinus. 
Of further interest was the significant variability 
between hearts with regard to regional microvascu- 
lar flow despite nearly identical perfusion pressures 
(see Table II). Such variability has also been docu- 
mented by Aldea and associates. 22In their excellent 
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study the coefiäcient of variation for retrograde 
cardioplegia was found to be 106% + 16%. The 
data presented within our paper support heir find- 
ings and also their suggestion of a complementary 
role for combined or sequential antegrade/retro- 
grade cardioplegia to maximize cardioplegic distri- 
bution. 
In conclusion, the data presented herein suggest 
that coronary sinus occlusion during retrograde 
administration of cardioplegic solution favorably 
affects cardioplegic distribution and improves over- 
all efficacy. In procedures in which the right atrium 
is open, retrograde perfusion is most easily achieved 
by placing a pursestring suture about the coronary 
sinus ostium. In procedures in which transatrial 
coronary sinus intubation is performed, the use of 
catheters that occlude or partially occlude the cor- 
onary sinus would be preferred. Continuous coro- 
nary sinus ostial occlusion results in antegrade flow 
being vented through t ebesian veins and not the 
coronary sinus. We and others have not found this 
to be injurious to the heart. 23 Although transatrial 
catheters that occlude the coronary sinus will elim- 
inate needless coronary ostial regurgitation and 
improve cardioplegic efficacy, they probably will not 
result in any significant positive change in right 
ventricular capillary flow unless they are positioned 
properly with respect o the orifice of the posterior 
intraventricular vein. 
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Discussion 
Dr. Steven R. Gundry (Loma Linda, Calif). Through- 
out the manuscript the authors take pain to point out that 
their experiment uses a nonoeclusive coronary sinus bal- 
loon catheter. This is what is commonly referred to as an 
autoinflating coronary sinus catheter. In the 1950s Dr. 
Lillehei and his colleagues working at the University of 
Minnesota introduced the concept of continuous ret- 
roperfusion of the heart with arterialized blood. In those 
days they achieved their retroperfusion by suturing into 
the coronary sinus their retroperfusion catheter and oc- 
cluding the coronary sinus with their pursestring suture. 
Interestingly enough, during this period was also the start 
of the Medtronics Corporation and their pacemaker tech- 
nology because of the number of injuries to the conduc- 
tion system that were caused by suturing around the 
coronary sinus. As you know, this technique gradually fell 
into disfavor. It was not until the mid-1980s when we 
introduced the concept of transatrial intubation of the 
coronary sinus that retrograde cardioplegia regained la- 
vor. I am therefore most interested in yonr study and 
several questions arise. 
First, where within the coronary sinus was your balloon 
catheter placed? 
Dr. Rudis. In all cases a PTFE tube was sutured to the 
opening of the coronary sinus. Dnring nonocclusive per- 
fusion the self-inflating retroperfusion catheter was placed 
through the PTFE tube to lie approximately 1 to 11/2 
inches from the coronary sinus ostium. During occlusive 
perfusion the retroperfusion catheter was pulled back into 
the PTFE tube and the proximal portion of the PTFE tube 
was made occlusive about the catheter. 
Dr. Gundry. Is there any reason that you did not 
initially position the balloon, even though it was a leaking 
balloon, at the coronary ostium? 
Dr. Rndis. Yes, in the experiment we tried to mimic the 
clinical situation by placing the catheter where we gener- 
ally put it during clinical retroperfusion. In most cases this 
will be distal to the posterior intraventricular vein in the 
coronary sinus. 
Dr. Gundry. In regard to the amount of regurgitation, 
Dr. Felipe Menasche recently published an article in The 
Annals of Thoracic Surgery comparing an autoinflating 
balloon with a manually inflating balloon using exactly the 
same method that you have used, collecting all etttuent 
from the coronary sinus through a PTFE tube. In that 
study he found a 30% regurgitant fraction using the 
autoinflating balloon and a 0% regurgitant fraction using 
the manually inflating balloon. Did you ever consider 
using a manually inflating balloon in your study to com- 
pare the leak rate caused by the autoinflating balloon 
versus the position of the balloon at the coronary sinus 
ostium? 
Dr. Rudis. The results of this study, as weil as Dr. 
Menasche's tudy, certainly suggest that a significant 
amount of cardioplegic solution is simply regurgitated 
back into the right atrium if there is no mechanism to 
make the retroperfusion catheter occlusive. Thus, if a 
purse-string suture is placed about the coronary sinus 
ostium or a manually inflating catheter is properly used, 
regurgitation can be eliminated and efficacy improved. 
Distribution is an entirely different matter. We believe 
that the improvement in cardioplegic distribution seen for 
the right ventricle in these studies was related to the equal 
pressure perfusion of the posterior intraventricular vein 
when compared with the distal coronary sinus. Clinically, 
this can be achieved by placing a purse-string suture about 
the coronary sinus ostium and introducing any type of 
retroperfusion catheter into the coronary sinus. If a 
manually inflating catheter is used, orte taust be certain 
that this is placed in the coronary sinus proximal to the 
posterior intraventricular vein to achieve equal pressure 
perfusion of this vein. As I am sure you know, the distance 
between the ostium of the coronary sinus and the poste- 
rior intraventricular vein is frequently very short. This 
often makes positioning of the manually inflating ret- 
roperfusion catheter suboptimal for perfusion of the 
posterior intraventricular vein. For these reasons we did 
not consider using the manually inflating catheter placed 
at the coronary sinus ostium for these experiments. 
Dr. Gundry. Last, you may be aware that at this year's 
Society of Thoracic Surgeons meeting we showed in 141 
human patients that there was equal distribution of nutri- 
ent blood flow to the right ventricle and left ventricle with 
high-flow continuous retrograde cardioplegia. We have 
suggested that one can overcome the limitations of bap 
loon placement by large volumes of retrograde cardiople- 
gic solution, literally stuffing all the available accesses out 
from the heart. Have you thought about whether changing 
the volumes of infused solution during your study would 
have made any difference? 
Dr. Rudis. Volume of flow is governed by perfusion 
pressure, which in these experiments was kept between 
30 and 40 mm Hg. In the laboratory we have increased 
flow by allowing higher pressures. Unfortunately, we 
have not found that this significantly affects distribu- 
tion, and on histologie examination we have noted 
edema formation and actual venous disruption with 
higher pressures. Thus we would advocate careful cath- 
eter positioning as opposed to increasing pressure/flow 
to improve distribution. 
Dr. George Cimochowski (Wilkes-Barre, Pa.). We have 
been interested in this problem for 3 years. When we 
routinely used warm retrograde cardioplegia nd the 
manually inflating balloon, as Dr. Gundry suggested, 
stone heart with hypertrophied ventricles developed in 
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three patients. We solved the problem in two ways. First, 
we switched to warm-cold-warm antegrade/retrograde 
cardioplegia, giving cold solution in the retrograde mode. 
Second, we designed a new large-volume catheter with 
Research Medical, Inc., Midvale, Utah. At the autopsy 
suite and the operating room we saw that eren with the 
regular balloon manual catheter there was significant 
regurgitation of the cardioplegic solution in patients with 
valve disease and hypertrophy. 
Dr. Rudis. It does appear as though both smaU and 
large hearts regurgitate about the coronary sinus when 
autoinflating retroperfusion cannulas are used. This 
problem is likely to be greater if the coronary sinus is 
grossly enlarged, as it offen is in massively hyper- 
trophied hearts. Cannulas that can deliver high volumes 
(300 to 450 ml/min) are required in massively hypertro- 
phied hearts if one is to maintain a perfusion pressure 
of 30 to 40 mm Hg. We do believe this is important. 
Bound vo lumes  ava i lab le  to subscr ibers  
Bound volumes of THE JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY are available to subscribers (only) for the 1995 
issues flora the Publisher, at a cost of $91.00 for domestic, $118.77 for Canadian, and $111.00 for international subscribers for Vol. 
109 (January-June) and Vol. 110 (July-December). Shipping charges are included. Each bound volume contains a subject and 
author index and all advertising is rernoved. Copies are shipped within 60 days after publieation ofthe last issue of the volume. The 
binding is durable buckram with the JOURNAL name, volume number, and year stamped in gold on the spine. Payment must 
accompany allorders. Contact Mosby-Year Book, Inc., Subscription Services, 11830 Westline Industrial Drive, St. Louis, Missouri 
63146-3318, USA; phone 1 (800) 453-4351 or (314) 453-435]. 
Subscriptions must be in force to qualify. Bound volumes are not available in place of a regular JOURNAL subseription, 
